Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Equity Average: 2023-2025

Historic Equity Average for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to $49.3 million.

  • Camp4 Therapeutics' Equity Average was N/A to $49.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.3 million, marking a year-over-year change of. This contributed to the annual value of -$30.3 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Camp4 Therapeutics reported Equity Average of $49.3 million as of Q3 2025, which was up 7.75% from $45.8 million recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Equity Average registered a high of $57.4 million during Q1 2025, and its lowest value of -$117.6 million during Q4 2023.
  • Moreover, its 3-year median value for Equity Average was $45.8 million (2025), whereas its average is -$2.6 million.
  • Data for Camp4 Therapeutics' Equity Average shows a peak YoY skyrocketed of 59.27% (in 2024) over the last 5 years.
  • Over the past 3 years, Camp4 Therapeutics' Equity Average (Quarterly) stood at -$117.6 million in 2023, then skyrocketed by 59.27% to -$47.9 million in 2024, then reached $49.3 million in 2025.
  • Its Equity Average stands at $49.3 million for Q3 2025, versus $45.8 million for Q2 2025 and $57.4 million for Q1 2025.